Cystoscopic Characteristic Findings of Interstitial Cystitis and Clinical Implications

Overview

Journal Tzu Chi Med J

Specialty General Medicine

Date 2024 Feb 26

PMID 38406570

Authors

Wan-Ru Yu

Yuan-Hong Jiang

Jia-Fong Jhang

Hann-Chorng Kuo

Affiliations

Soon will be listed here.

Abstract

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic inflammatory bladder disease of unknown etiology, characterized by bladder pain and frequency urgency symptoms. Based on the cystoscopic findings after hydrodistention under anesthesia, the phenotype of IC/BPS includes no glamerulation, characteristic glomerulation, and with Hunner's lesion. IC is specifically defined if there are characteristic Hunner's lesion appeared in cystoscopy or after hydrodistention. If there are glomerulations without Hunner's lesion, BPS should be considered. The definition of Hunner's lesion and glomerulations differs based on different definition and observations. Currently, there has been no clear description and grading of the glomerulations and Hunner's lesion. Because the classification of IC/BPS has an impact on the treatment strategy and associated with therapeutic outcome, it is unmet to have a clear definition and consensus on the characteristic cystoscopic findings of IC/BPS. This article reviews the literature and presents the figures of Hunner's lesions and description of different mucosal lesions after cystoscopic hydrodistention.

Citing Articles

Repeated intravesical injections of platelet-rich plasma are safe and effective in the treatment of interstitial cystitis/bladder pain syndrome.

Yu W, Jiang Y, Jhang J, Kuo H Tzu Chi Med J. 2025; 37(1):72-79.

PMID: 39850397 PMC: 11753520. DOI: 10.4103/tcmj.tcmj_166_24.

Pelvic floor muscle pain is associated with higher symptom scores and bladder pain perception in women with interstitial cystitis and bladder pain syndrome.

Yu W, Jhang J, Jiang Y, Kuo H World J Urol. 2024; 43(1):9.

PMID: 39625572 DOI: 10.1007/s00345-024-05366-7.

The Pathomechanism and Current Treatments for Chronic Interstitial Cystitis and Bladder Pain Syndrome.

Yu W, Jhang J, Jiang Y, Kuo H Biomedicines. 2024; 12(9).

PMID: 39335564 PMC: 11428245. DOI: 10.3390/biomedicines12092051.

Urine biomarker could be a useful tool for differential diagnosis of a lower urinary tract dysfunction.

Yu W, Jiang Y, Jhang J, Kuo H Tzu Chi Med J. 2024; 36(2):110-119.

PMID: 38645782 PMC: 11025593. DOI: 10.4103/tcmj.tcmj_221_23.

References

Yu W, Jhang J, Ho H, Jiang Y, Lee C, Hsu Y . Cystoscopic hydrodistention characteristics provide clinical and long-term prognostic features of interstitial cystitis after treatment. Sci Rep. 2021; 11(1):455. PMC: 7801576. DOI: 10.1038/s41598-020-80252-x. View

Lee Y, Jhang J, Jiang Y, Hsu Y, Ho H, Kuo H . Difference in electron microscopic findings among interstitial cystitis/bladder pain syndrome with distinct clinical and cystoscopic characteristics. Sci Rep. 2021; 11(1):17258. PMC: 8390653. DOI: 10.1038/s41598-021-96810-w. View

Jhang J, Ho H, Jiang Y, Lee C, Hsu Y, Kuo H . Electron microscopic characteristics of interstitial cystitis/bladder pain syndrome and their association with clinical condition. PLoS One. 2018; 13(6):e0198816. PMC: 5991750. DOI: 10.1371/journal.pone.0198816. View

Messing E, Stamey T . Interstitial cystitis: early diagnosis, pathology, and treatment. Urology. 1978; 12(4):381-92. DOI: 10.1016/0090-4295(78)90286-8. View

Lin C, Liu C, Hsieh H, Chen M, Tsai C . Changes in Cystoscopic Findings after Intravesical Hyaluronic Acid Instillation Therapy in Patients with Interstitial Cystitis. Diagnostics (Basel). 2022; 12(8). PMC: 9407291. DOI: 10.3390/diagnostics12082009. View

Jiang Y, Jhang J, Kuo H . Revisiting the Role of Potassium Sensitivity Testing and Cystoscopic Hydrodistention for the Diagnosis of Interstitial Cystitis. PLoS One. 2016; 11(3):e0151692. PMC: 4801189. DOI: 10.1371/journal.pone.0151692. View

Tamaki M, Saito R, Ogawa O, Yoshimura N, Ueda T . Possible mechanisms inducing glomerulations in interstitial cystitis: relationship between endoscopic findings and expression of angiogenic growth factors. J Urol. 2004; 172(3):945-8. DOI: 10.1097/01.ju.0000135009.55905.cb. View

Hoke T, Goldstein H, Saks E, Vakili B . Hydrodistention of the bladder for the treatment of bladder pain syndrome/interstitial cystitis (BPS/IC). Neurourol Urodyn. 2016; 36(3):784-786. DOI: 10.1002/nau.23024. View

Shie J, Liu H, Wang Y, Kuo H . Immunohistochemical evidence suggests repeated intravesical application of botulinum toxin A injections may improve treatment efficacy of interstitial cystitis/bladder pain syndrome. BJU Int. 2012; 111(4):638-46. DOI: 10.1111/j.1464-410X.2012.11466.x. View

10.

Homma Y, Akiyama Y, Tomoe H, Furuta A, Ueda T, Maeda D . Clinical guidelines for interstitial cystitis/bladder pain syndrome. Int J Urol. 2020; 27(7):578-589. DOI: 10.1111/iju.14234. View

11.

Rofeim O, Hom D, Freid R, Moldwin R . Use of the neodymium: YAG laser for interstitial cystitis: a prospective study. J Urol. 2001; 166(1):134-6. View

12.

van de Merwe J, Nordling J, Bouchelouche P, Bouchelouche K, Cervigni M, Daha L . Diagnostic criteria, classification, and nomenclature for painful bladder syndrome/interstitial cystitis: an ESSIC proposal. Eur Urol. 2007; 53(1):60-7. DOI: 10.1016/j.eururo.2007.09.019. View

13.

Jhang J, Jiang Y, Hsu Y, Ho H, Kuo H . Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner's lesion and grade 3 glomerulation might be different from other types of patients. Int J Urol. 2021; 28(8):823-830. DOI: 10.1111/iju.14585. View

14.

Homma Y, Ueda T, Tomoe H, Lin A, Kuo H, Lee M . Clinical guidelines for interstitial cystitis and hypersensitive bladder syndrome. Int J Urol. 2009; 16(7):597-615. DOI: 10.1111/j.1442-2042.2009.02326.x. View

15.

Whitmore K, Fall M, Sengiku A, Tomoe H, Logadottir Y, Kim Y . Hunner lesion versus non-Hunner lesion interstitial cystitis/bladder pain syndrome. Int J Urol. 2019; 26 Suppl 1:26-34. DOI: 10.1111/iju.13971. View

16.

Gohritz A, Dellon A . Bladder Pain Syndome/Interstitial Cystitis due to Pudendal Nerve Compression: Described in 1915-A Reminder for Treating Pelvic Pain a Century Later. J Brachial Plex Peripher Nerve Inj. 2020; 15(1):e5-e8. PMC: 7060083. DOI: 10.1055/s-0039-1700538. View

17.

Proano A, Garde G, Garrido G, Mazza O . [ESSIC criteria for the diagnosis of bladder pain syndrome/interstitial cystitis (BPS/IC) and comparison with the NIDDK criteria]. Arch Esp Urol. 2013; 66(2):206-14. View

18.

Akiyama Y, Hanno P . Phenotyping of interstitial cystitis/bladder pain syndrome. Int J Urol. 2019; 26 Suppl 1:17-19. DOI: 10.1111/iju.13969. View

19.

Jiang Y, Jhang J, Hsu Y, Kuo H . Usefulness of Urinary Biomarkers for Assessing Bladder Condition and Histopathology in Patients with Interstitial Cystitis/Bladder Pain Syndrome. Int J Mol Sci. 2022; 23(19). PMC: 9569433. DOI: 10.3390/ijms231912044. View

20.

Kuo Y, Kuo H . The urodynamic characteristics and prognostic factors of patients with interstitial cystitis/bladder pain syndrome. Int J Clin Pract. 2013; 67(9):863-9. DOI: 10.1111/ijcp.12116. View